OH SB198

Drug manufacturers, repackagers, and third-party logistics providers are prohibited from denying, restricting, or discriminating against 340B covered entities in acquiring or receiving 340B-priced drugs, unless prohibited by federal HHS

Manufacturers cannot require 340B grantees to submit claims or utilization data as a condition for drug access, unless required by federal HHS

Violations constitute unfair and deceptive insurance practices, with civil penalties of $50,000 per violation (each drug package counts as separate violation) up to $10 million annually

The Superintendent of Insurance may refer violations to the State Board of Pharmacy for additional sanctions against licensees

The bill expands existing definitions in Ohio Revised Code to include manufacturers, repackagers, and third-party logistics providers of dangerous drugs